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Members of the carotenoid cleavage 
dioxygenase family catalyse the oxidative 
cleavage of carotenoids at various chain 
positions, leading to the formation of a wide 
range of apocarotenoid signalling molecules. To 
explore the functions of this diverse enzyme 
family, we have used a chemical genetic 
approach to design selective inhibitors for 
different classes of carotenoid cleavage 
dioxygenase. A set of 18 arylalkyl-hydroxamic 
acids was synthesised in which the distance 
between an iron-chelating hydroxamic acid and 
an aromatic ring was varied; these compounds 
were screened as inhibitors of four different 
enzyme classes, either in vitro or in vivo. Potent 
inhibitors were found that selectively inhibited 
enzymes that cleave carotenoids at the 9,10 
position; 50% inhibition was achieved at sub-
micromolar concentrations. Application of 
certain inhibitors at 100 µM to Arabidopsis  
node explants or whole plants led to increased 
shoot branching, consistent with inhibition of 
9,10-cleavage. 
 
Carotenoids are synthesised in plants and 
micro-organisms as photoprotective molecules and 
are key components in animal diets, an example 
being β-carotene (pro-vitamin A). The oxidative 
cleavage of carotenoids occurs in plants, animals, 
and micro-organisms and leads to the release of a 
range of apocarotenoids that function as signalling 
molecules with a diverse range of functions (1). 
The first gene identified as encoding a carotenoid 
cleavage dioxygenase (CCD)1 was the maize Vp14 
gene that is required for the formation of abscisic 
acid (ABA), an important hormone that mediates 
responses to drought stress and aspects of plant 
development such as seed and bud dormancy (2). 
The VP14 enzyme cleaves at the 11,12 position 
(Fig. 1) of the epoxycarotenoids 9′-cis-neoxanthin 
and/or 9-cis-violaxanthin and is now classified as 
a 9-cis-epoxycarotenoid dioxygenase (NCED) (3), 
a subclass of the larger CCD family. 
Since the discovery of Vp14, many other CCDs 
have been shown to be involved in the production 
of a variety of apocarotenoids (Fig. 1). In insects, 
the visual pigment retinal is formed by oxidative 
cleavage of β-carotene by β-carotene-15,15′-
dioxygenase (4). Retinal is produced by an 
orthologous enzyme in vertebrates, where it is also 
converted to retinoic acid, a regulator of 
differentiation during embryogenesis (5). A 
distinct mammalian CCD is believed to cleave 
carotenoids asymmetrically at the 9,10 position (6) 
and, although its function is unclear, recent 
evidence suggests a role in the metabolism of 
dietary lycopene (7). The plant volatiles β-ionone 
and geranylacetone are produced from an enzyme 
that cleaves at the 9,10 position (8) and the 
pigment α-crocin found in the spice saffron results 
from an 7,8-cleavage enzyme (9). 
Other CCDs have been identified where 
biological function is unknown, for example in 
Cyanobacteria where a variety of cleavage 
specificities have been described (10-12). In other 
cases there are apocarotenoids with known 
functions, but the identity or involvement of CCDs 
have not yet been described: grasshopper ketone is 
a defensive secretion of the flightless grasshopper 
Romalea microptera (13), mycorradicin is 
produced by plant roots during symbiosis with 
arbuscular mycorrhyza (14), and strigolactones 
(15) are plant metabolites that act as germination 
signals to parasitic weeds such as Striga and 
Orobanche (16). 
Recently it was discovered that strigolactones 
also function as a branching hormone in plants 
(17,18). The existence of such a branching 
hormone has been known for some time, but its 
identity proved elusive. However, it was known 
that the hormone was derived from the action of at 
least two CCDs, max3 and max4 (more axillary 
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growth) (19), because deletion of either of these 
genes in Arabidopsis thaliana, leads to a bushy 
phenotype (20,21). In E. coli assays, AtCCD7 
(max3) cleaves β-carotene at the 9,10 position and 
the apocarotenoid product (10-apo-β-carotene) is 
reported to be further cleaved at 13,14 by AtCCD8 
(max4) to produce 13-apo-β–carotene (22). Also 
recent evidence suggests that AtCCD8 is highly 
specific, cleaving only 10-apo-β-carotene (23). 
How the production of 13-apo-β–carotene leads to 
the synthesis of the complex strigolactone is 
unknown. The possibility remains that the 
enzymes may have different specificities and 
cleavage activities in planta. In addition, a 
cytochrome P450 enzyme (24) is believed to be 
involved in strigolactone synthesis and acts in the 
pathway downstream of the CCD genes. 
Strigolactone is thought to effect branching by 
regulating auxin transport (25). Because of the 
involvement of CCDs in strigolactone synthesis, 
the possibility arises that plant architecture and 
interaction with parasitic weeds and mycorrhyza 
could be controlled by the manipulation of CCD 
activity. 
Although considerable success has been 
obtained using genetic approaches to probe 
function and substrate specificity of CCDs in their 
native biological contexts, particularly in plant 
species with simple genetic systems or that are 
amenable to transgenesis, there are many systems 
where genetic approaches are difficult or 
impossible. Also, when recombinant CCDs are 
studied either in vitro or in heterologous in vivo 
assays, such as in E. coli strains engineered to 
accumulate carotenoids (26), they are often active 
against a broad range of substrates (5,21,27), and 
in many cases the true in vivo substrate of a 
particular CCD remains unknown. Therefore 
additional experimental tools are needed to 
investigate both apocarotenoid and CCD functions 
in their native cellular environments. 
In the reverse chemical genetics approach, 
small molecules are identified that are active 
against known target proteins; they are then 
applied to a biological system to investigate 
protein function in vivo (28,29). This approach is 
complementary to conventional genetics since the 
small molecules can be applied easily to a broad 
range of species, their application can be 
controlled in dose, time and space to provide 
detailed studies of biological functions, and 
individual proteins or whole protein classes may 
be targeted by varying the specificity of the small 
molecules. Notably, functions of the plant 
hormones gibberellin, brassinosteroid and abscisic 
acid have been successfully probed using this 
approach by adapting triazoles to inhibit specific 
cytochrome P450 monooxygenases involved in the 
metabolism of these hormones (30). 
In the case of the CCD family, the tertiary 
amines abamine (31) and the more active 
abamineSG (32) were reported as specific 
inhibitors of NCED, and abamine was used to 
show new functions of abscisic acid in legume 
nodulation (33). However, no selective inhibitors 
for other types of CCD are known. Here we have 
designed a novel class of CCD inhibitor based on 
hydroxamic acids, where variable chain length 
was used to direct inhibition of CCD enzymes that 
cleave carotenoids at specific positions. We 
demonstrate the use of such novel inhibitors to 
control shoot branching in a model plant. 
 
EXPERIMENTAL PROCEDURES 
Synthesis of tertiary amine inhibitors—
Abamine was synthesised according to published 
procedures (31,34).  
Synthesis of hydroxamic acid inhibitors—
Synthesis is shown in Fig. 2 and structures are 
given in Table 1. N-Boc,O-benzyl-hydroxylamine 
was treated with NaH in DMF, followed by the 
appropriate benzyl or alkyl bromide (35). 
Deprotection was carried out by treatment with 
1% trifluoroacetic acid in dichloromethane, to give 
the N-substituted hydroxylamine. Hydroxamic 
acid formation was carried out using DCC (1.1 
equiv.) and 4-dimethylaminopyridine (0.2 equiv.) 
and the appropriate carboxylic acid, in 
dichloromethane. The hydroxamic acid products 
were purified by silica gel column 
chromatography. B1, D12 and D13 were prepared 
by activation of the appropriate acid with methyl 
chloroformate and triethylamine in THF, and 
reaction with hydroxylamine hydrochloride. The 
intermediate for synthesis of B1 was synthesised 
from β-ionone (36); B1 was isolated as a 2:1 
mixture of E/Z isomers. Spectroscopic data and 
yields for analogues D1-D13, F1-4, and B1 are 
available as supplemental data. 
In vitro NCED enzyme assay—We over-
expressed LeNCED1 in E. coli, as an N-terminal 
His6-fusion protein (supplemental methods). Cell-
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free extract containing recombinant LeNCED1 
was prepared in 100 mM bis-tris buffer (pH 6.7). 
15 µl extract was pre-activated by addition of iron 
(II) sulphate (20 mM, 1 µl) and ascorbic acid (20 
mM, 1 µl) on ice for 2 min, prior to use. This 
aliquot of enzyme was then added to an assay (150 
µl total volume) containing 100 mM bis-tris buffer 
(pH 6.7), 0.05% v/v Triton X-100, 1.0 mg ml-1 
catalase, and 3 µg 9′-cis-neoxanthin. The 9′-cis-
neoxanthin substrate was prepared as described in 
supplemental methods. The enzyme assay was 
incubated for 15 min in the dark at 20oC. Water 
(700 µl) was then added, and the products 
extracted with ethyl acetate (3 x 1 ml). The 
organic solvent was removed at reduced pressure, 
the residue was dissolved in methanol (200 µl), 
and then 100 µl was injected onto a Phenomenex 
C18 reverse phase HPLC column, and a gradient of 
5-10% methanol in acetonitrile/0.05% 
triethylamine was applied at 0.5 ml min-1 over 20 
min, detecting at 440 nm. NCED inhibition assays 
contained 1-100 µM inhibitor; inhibition was 
calculated from the product formation after 15 
min, compared to a control assay with no inhibitor 
present. Retention times: 9′-cis-neoxanthin, 10.2 
min; C25 product, 6.5 min. 
In vitro LeCCD1a enzyme assay—We over-
expressed LeCCD1a in E. coli, as a GST-fusion 
protein (supplemental methods). The in vitro assay 
of LeCCD1a was based on reported methods (37), 
and was carried out in a 200 µl total volume in a 
96-well microtitre plate, with the signal detected at 
485 nm. To prepare substrate solution for each 
assay, 5 µl of 4% (w/v in ethanol) apo-8′-carotenal 
(Sigma) was mixed with 25 µl of 4% (w/v in 
ethanol) β-octylglucoside (Sigma), the ethanol was 
then evaporated under nitrogen, and the residue 
dissolved in 150 µl PBS buffer containing 10 mM 
sodium ascorbate by incubation at 20oC for 30 
min. 50 µl of cell-free extract containing 
recombinant LeCCD1a was added, and the 
reactions monitored over 30 min at 20oC. 
In vivo enzyme assays in E. coli—The genes 
of interest (supplemental Table S1) were cloned 
into the vector pET30c (Novagen) fused directly 
to the initial ATG codon with no tag, or into 
pGEX-4T such that the gene was fused to an N-
terminal GST tag. All genes were full length 
except AtCCD7, which had the chloroplast signal 
sequence removed (supplemental methods). This 
gene, when fused to GST in the pGEX-4t vector 
(GE Healthcare), showed greater CCD activity 
than when expressed in a pET vector without a 
tag. Therefore, this construct was used in 
subsequent assays. The plasmids were transferred 
to the E. coli expression strain BL21(DE3), 
harbouring pAC-BETA (38), and therefore 
producing β-carotene. 
For each inhibitor assay, 2.5 ml LB media with 
the appropriate antibiotics (25 μg ml-1 
chloramphenicol and 50 μg ml-1 kanamycin or 100 
μg ml-1 ampicillin) and 2.5 μM IPTG, was 
prepared. Inhibitors (0.1 M in 100% ethanol) were 
added to the media to a final concentration of 100 
μM. The media was then inoculated with 0.25 ml 
of overnight culture (grown at 370C with the 
appropriate antibiotics) and incubated with 
shaking (200 rpm) at 280C for 16 hours. One ml of 
culture was harvested by microcentrifugation and 
resuspended thoroughly in 1 ml ethanol containing 
0.2 % Triton X-100. After vortexing, the extract 
was incubated at room temperature in the dark for 
3 hours, again vortexed and then spun in a 
microcentrifuge for 5 min at 13000 rpm. The 
supernatant was removed and the O.D.453 – O.D.550 
was measured. The amount of β-carotene was 
calculated using a standard curve generated from a 
dilution series of β-carotene (Sigma) in ethanol 
with 0.2% Triton X-100 (supplemental Fig. S1).   
The relative inhibition was calculated by the 
equation: (Ci-Cc)/(Cl-Cc) x 100, where Ci is the 
carotenoid level with inhibitor and CCD present, 
Cc is the level with CCD but without the inhibitor 
and Cl is the level in a strain where lacZ is 
expressed instead of the CCD, and no inhibitor is 
present. Thus the increase in β-carotene due to 
inhibition of the CCD (Ci-Cc) was expressed 
relative to the maximum possible β-carotene 
content when CCD is absent (Cl-Cc). 
Growth of Arabidopsis—Wild-type (ecotype 
Col-0) and the max3-9 mutant in the Col-0 
background (21) were grown in double Magenta 
pots (Sigma) on 30 ml ATS media (39) containing 
1% sucrose and 0.8% agar, supplemented, where 
stated, with 100 μM inhibitor from a 100 mM 
stock in ethanol. Seeds were sterilized by 
immersion for 1 min in 70% ethanol and 4 min in 
50% household bleach before being washed 5 
times in distilled water. Six seeds were placed in 
each Magenta pot, they were vernalized in the 
dark at 4oC for two days and then placed in a 
growth room (24OC, 16 hr light period, 150 μmol 
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m2 s-1 photosynthetically active radiation) for 45 
days before being photographed. Side shoots from 
rosette nodes were counted for each plant.  
Axillary bud outgrowth assay in Arabidopsis 
stem sections—The assays were performed 
essentially as described (40) with the following 
modifications. Small Petri dishes (50 mm 
diameter, 20 mm depth) were filled with 10 ml of 
ATS (39) supplemented with 1% agar and 1% 
sucrose. Inhibitors and α-naphthalene acetic acid 
(NAA) were added to the agar before pouring to 
give 100 μM and 1 μM, respectively. Thus, when 
the central strip was cut out of the agar, both the 
apical and basal media contained both NAA and 
inhibitor. Any nodes in which the apical end had 
curled out of the media or which bud length was 
less than 2 mm at the end of the experiment were 
discounted. Measurement of the shoot length was 
performed every 24 hours. For each assay a 
logistic curve was fitted using Genstat (10th 
edition, VSN international) with the fitcurve 
directive and the lag phase was calculated by 
extrapolating the linear part of the curve and the 
initial plateau (see supplementary methods). The x 
value of where these two lines intersected 
represented the lag phase. 
Statistical analysis—For data in Fig. 4 and 5 
analysis was by Residual Maximum Likelihood 
(REML) in Genstat10.  In both cases an F-test 
showed that overall the treatment effects were 
highly significant (P < 0.001). The maximum 
value of the least significant difference (LSD) was 
calculated by multiplying the maximum standard 
error of differences by a t-value (P = 0.05), and is 
presented on the graphs. There were 105 and 157 
degrees of freedom for the LSDs shown in Fig. 4 
and 5 respectively. The maximum LSD was used 
because individual LSDs varied but if differences 
between means were significant using the 
maximum values then they were also significantly 
different at the individual value for any two 
selected means. 
 
RESULTS 
Inhibitor design and synthesis—NCED was 
proposed to be a dioxygenase (3), with a reaction 
mechanism involving a carbocation intermediate, 
followed by formation of a dioxetane ring or a 
Criegee rearrangement prior to cleavage (41); such 
a mechanism was supported by 18O labelling 
experiments with AtCCD1 (37), and was the most 
likely mechanism based on computational studies 
of the ACO crystal structure (42). 
It was reported that the tertiary amine abamine 
(see Fig. 3a for structure) is a reversible 
competitive inhibitor (Ki = 39 µM) of recombinant 
NCED and that it inhibited abscisic acid 
production in planta at 50-100 µM concentration 
(31). AbamineSG, with an extended 3 carbon 
linker between the methyl ester and the nitrogen 
atom, was subsequently developed with an 
improved activity (Ki = 18.5 μM) (32). The precise 
mechanism of action of abamine is uncertain, but 
our hypothesis was that the protonated amine 
mimics a carbocation intermediate in the catalytic 
mechanism, with the oxygenated aromatic ring 
bound in place of the hydroxy-cyclohexyl 
terminus of the carotenoid substrates (41), as 
shown in Fig. 3.  Inhibition may be due in part to 
chelation of the essential metal ion cofactor by the 
methyl ester of abamine  However, a derivative of 
abamine, containing an acid group (COOH) in 
place of the methyl ester, was not active (32), even 
though in theory this should be more effective at 
binding the iron cofactor 
Hydroxamic acids are known to act as 
inhibitors of several different classes of 
metalloenzymes, such as the matrix 
metalloproteases, by chelation of the essential 
metal ion cofactor (43). Therefore, hydroxamic 
acid analogues were synthesised, in which the 
hydroxy-cyclohexyl terminus of the carotenoid 
substrate was mimicked as above by an 
oxygenated aromatic ring, and the hydroxamic 
acid functional group was positioned at variable 
distance from the aromatic ring. Thus, a collection 
of aryl-C3N analogues (D8-D13), aryl-C2N 
analogues (D1-D7), and aryl-C1N analogues (F1-
F4) was also synthesised (Table 1). The 4-
fluorobenzyl substituent, found to promote activity 
in the abamine series (31), was included in the 
collection of hydroxamic acids. The synthetic 
route, shown in Fig. 2, involves coupling of the 
appropriate acid with a substituted O-benzyl 
hydroxylamine, followed by deprotection. One 
hydroxamic acid containing a longer C5 spacer 
from a cyclohexyl moiety (B1) was also 
synthesised from β-ionone. A set of 18 
hydroxamic acids was then used for inhibitor 
screening; numbering of chemical compounds is 
given in Table 1. 
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Specificity of inhibition in vitro for tomato 
genes LeNCED1 and LeCCD1a—In order to 
screen the inhibitors against enzymes which cleave 
carotenoids at the 9,10 position, we used the 
recombinant tomato LeCCD1a  protein (44), 
because this type of enzyme can be studied using 
an in vitro colourimetric assay with β-apo-8′-
carotenal as substrate (37). To establish the 
specificity of the inhibitors, they were also tested 
against the tomato LeNCED1 recombinant protein 
which cleaves 9-cis carotenoids at the 11,12 
position (45). For this enzyme, the cleavage 
reaction was monitored by C18 reverse phase 
HPLC, using 9′-cis-neoxanthin as substrate. As 
reported by others (46), each enzyme activity was 
found to be unstable (lifetime < 24 h) towards 
storage or purification, therefore enzyme assays 
were carried out using recombinant cell-free 
extract (no cleavage activity was observed using 
E. coli extract lacking the recombinant CCD 
gene). 
Against LeNCED1, several hydroxamic acids 
(notably D8, D7, and D4) showed 1.5-2 fold 
higher inhibitory activity than the designated 
NCED inhibitor, abamine (31), which in our hands 
showed only 20% inhibition at 100 µM 
concentration (see Table 1). Against LeCCD1a, 
potent inhibition was observed by all the aryl-C2N 
hydroxamic acids, and certain other hydroxamic 
acids. 4-methoxyaryl hydroxamic acids were 
effective inhibitors in each series, but the most 
potent inhibition was observed with the 4-
hydroxyaryl hydroxamic acids D1, D2, and D3, 
which gave IC50 values of 0.8-0.9 µM. In contrast, 
abamine gave an IC50 value of 210 μM against 
LeCCD1a (Table 1). 
Comparison of inhibition data for LeNCED1 
and LeCCD1a shows that all the active 
compounds show some selectivity towards 
LeCCD1a, with compounds D3, F1, and F2 
showing high levels of inhibition of LeCCD1a, 
and little or no inhibition of LeNCED1 (Table 1).  
In vivo activity of inhibitors applied to E. coli 
strains expressing CCDs—Coloured E. coli strains 
that produce various carotenoids can be 
constructed by expression of enzymes for 
carotenoid synthesis (26).  Upon co-expression of 
the appropriate CCD, the bacteria lose their colour 
due to cleavage of the carotenoids to colourless 
products (4,6,27). This technique was employed 
here to further explore the specificity of inhibitors, 
and to test their activity in vivo. The level of 
carotenoid in each CCD-expressing strain was 
compared to the level of the carotenoid in a 
control strain producing β-carotene but lacking 
any CCD gene. The difference in the carotenoid 
levels gave a measure of CCD activity, and 
inhibition of this activity was measured by 
addition of inhibitors to the growing medium. 
The inhibitors were tested against four β-
carotene-producing E. coli strains (supplemental 
Table S1). Three of the strains expressed highly 
divergent CCDs that cleave at the 9,10 position: 
AtCCD7 from Arabidopsis (21) and MmBCO2 
from mouse (6) which both cleave at a single site 
(9,10 or  9′,10′ but not both), and the tomato 
enzyme LeCCD1a (44) which cleaves at both sites 
in the same substrate molecule (9,10/9′,10′ 
activity). The fourth strain expressed another 
mouse CCD, MmBCO1 (47), which cleaves 
centrally at 15,15′. Ourselves and other researchers 
(48) have found that expressing CCDs (and 
presumably other proteins) can lead to loss of 
carotenoids by non-specific means. However, 
detection of cleavage products by HPLC in the E. 
coli cells and media confirmed that in all four 
strains used here, CCD cleavage was the cause of 
carotenoid loss. NCED activity could not be 
studied in E. coli cells because the enzyme 
required for production of the 9-cis carotenoid 
substrates of NCED has not yet been identified. 
We synthesized the genes CsZCD (9) and BoLCD 
(49), expressed them in E. coli, and looked for the 
reported 5,6 and 7,8 cleavage activities both in 
vitro and in E. coli cells. However, we were not 
able to detect activity, and so it was not possible to 
test inhibitors against the 5,6 and 7,8 cleavage 
specificities. 
The compounds showed different patterns of 
inhibition against the three 9,10 enzymes (Fig. 4). 
The activity of the compounds against LeCCD1a 
in vivo (Fig. 4) mirrored the activity observed in 
vitro (Table 1): D5 and D6 exhibited relatively 
weaker inhibition activity than the other D 
compounds and F3 exhibited virtually none. A 
different pattern was obtained with AtCCD7 in the 
E. coli system (Fig. 4), with the compounds F1 
and F2, which exhibited good activity against 
LeCCD1a, showing poor inhibition. In contrast F1 
and F2 were the most effective compounds at 
inhibiting MmBCO2 (Fig. 4). The 15,15′ cleavage 
enzyme MmBCO1 was not inhibited to any 
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significant extent by any of the compounds tested 
(Fig. 4). 
Stimulation of shoot branching in Arabidopsis 
stem sections by application of inhibitor—Auxin 
inhibits the outgrowth of axillary buds in wild-
type Arabidopsis plants. In the AtCCD7 and 
AtCCD8 null mutants (max3 and max4, 
respectively) the response to auxin is reduced, 
presumably due to a block in formation of an 
apocarotenoid  hormone (recently shown (17,18) 
to be strigolactone or a related compound) that 
suppresses branching (19), and axillary buds 
extend earlier, leading to formation of side 
branches. An in vitro assay was previously 
developed in which the growth of axillary buds 
from isolated sections of Arabidopsis stem was 
used to assess max mutants (40). In such assays, it 
was reported that bud outgrowth of the max4-1 
mutant (AtCCD8) was 2 days earlier than for wild-
type (20) and a similar phenotype is expected of 
the highly branched max3-9 mutant (21). We 
tested hydroxamic acid inhibitors at 100 μM in 
this assay and found that D1 to D6, and F3 all 
significantly (P < 0.05) advanced the timing of 
bud outgrowth in wild-type, with the advancement 
ranging from one day (D1) to three days (D3) (Fig. 
5). This earlier bud outgrowth was equivalent to 
that observed in the AtCCD7 null mutant max3-9 
(Fig. 5), and indicates an inhibition of AtCCD7 
and/or possibly AtCCD8 in this tissue. The effect 
of the inhibitors in this assay only partially 
mirrored the activities in the E. coli assay, with 
compounds F1 and F2 having a relatively small 
activity in both the bud outgrowth assay (Fig. 5) 
and the E. coli AtCCD7 assay (Fig. 4). However, 
in the case of F3 there was disagreement because 
it was inactive in the E. coli assay for AtCCD7, 
but it was active in stimulating bud outgrowth. 
One possibility in this case is that F3 stimulated 
branching by inhibiting AtCCD8 (not tested in 
vitro or in E. coli) rather than AtCCD7. 
Stimulation of shoot branching in whole 
Arabidopsis plants—Inhibitors were also applied 
to Arabidopsis whole plants grown under sterile 
conditions in agar. The max3-9 plants (Fig. 6b) 
and those treated with D2, D4, D5 and D6 (Fig. 6c 
shows D6 treated plants) exhibited a bushy 
appearance compared to the untreated wild-type 
controls (Fig. 6a). This bushy appearance was due 
to the increased number of side branches from the 
rosette nodes, with max3-9 plants exhibiting 3 to 4 
side branches compared to a mean of 0.25 for wild 
type. Inhibitor treated plants were intermediate 
(mean of approximately 2 branches) and so 
partially mimicked max3-9 (Fig. 6d).  
F1 and F2 were toxic to whole plants at 100 
μM (data not shown). D3 was active in the stem 
section assay (Fig. 5), but in whole plants D3 had 
a negative effect on Arabidopsis growth when 
added to the agar media, and a toxicity effect was 
suggested by the observation that roots grew 
across the agar surface rather than penetrating. 
This general growth effect may have masked any 
possible stimulatory effects of D3 on side 
branching. 
 
DISCUSSION 
We have designed and tested a new class of 
inhibitor of the carotenoid cleavage dioxygenase 
family that is based on a structural mimic of the 
substrate that positions an iron-chelating 
hydroxamic acid group within the active site. 
Positioning was achieved by varying the distance 
between the hydroxamic acid and an aromatic ring 
so that it matched the distance within the 
carotenoid substrate between the proximal cyclic 
end-group and the cleavage site. Crystal structure 
of ACO, a cyanobacterial CCD, indicates that 
cleavage position is likely to be determined by the 
distance between the Fe(II) catalytic centre and the 
opening of the long non-polar tunnel that allows 
access to carotenoid substrates (11). This idea is 
supported by the observation that for NosCCD 
(from Nostoc sp. PCC 7120) cleavage of the 
monocyclic γ-carotene occurs at the 7′,8′ position 
where the proximal terminus is linear, but at the 
9,10 position when the proximal terminus has a 
more compact cyclic end group (48); indeed it was 
suggested that the cyclic end group may be 
arrested at the entrance of the tunnel (48). 
We predicted from this crystal structure, and 
our model for the cleavage mechanism (Fig. 3), 
that aryl-C1N, aryl-C2N and aryl-C3N compounds 
would be selective for 7,8, 9,10 and 11,12 
cleavage reactions, respectively; we tested these 
classes against enzymes with 9,10, 11,12 and 
15,15′ specificities. Certain aryl-C1N compounds 
(F1, F2) were effective inhibitors of 9,10 but not 
11,12 or 15,15′ cleavages. The aryl-C2N 
compounds were potent inhibitors of 9,10 
enzymes, but also had a moderate 11,12 inhibition 
activity. The aryl-C3N compounds were much less 
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potent against 9,10 enzymes, and although this 
group contained the best 11,12 inhibitor (D8), they 
all still maintained a somewhat greater selectivity 
towards the 9,10 cleavage. In comparison, a 
further analogue, abamineSG, was reported to be 
more active against the 11,12 cleavage than the 
9,10 cleavage; at 100 μM it inhibited AtNCED3 
by 78% and AtCCD1 by ≤ 20% (32). None of the 
compounds tested inhibited the 15,15′ enzyme, 
presumably because the spacing was too small.  
Thus we conclude that the strategy of varying the 
positioning of the hydroxamic acid group was only 
moderately successful, since some overlap existed 
between the classes. Nevertheless, individual 
compounds were identified with very high 
specificity to the 9,10 cleavage in vitro, e.g. IC50 
for F1 was 2.0 μM but no inhibition of LeNCED1 
was detected. 
The inhibitors also exhibited different patterns 
of activity in E. coli against the three different 
enzymes with 9,10 cleavage activity. For example, 
F1 and F2 had high inhibitory activity against 
LeCCD1a and MmBCO2 but were relatively 
ineffective against AtCCD7. Such differences are 
not surprising since MmBCO2 shares only 17-
23% amino acid identity with the two plant 9,10 
enzymes (LeCCD1a and AtCCD7), which are 
themselves highly divergent, with only 19% 
identity to each other. This indicates that the 
variants of the hydroxamic inhibitors are able to 
distinguish between enzymes that have similar 
activities but highly divergent primary structure. 
The E. coli system proved useful in measuring 
the efficacy of the inhibitors in vivo. For example, 
the E. coli assays showed F1 and F2 were poor 
inhibitors against AtCCD7 and this was confirmed 
in the Arabidopsis bud outgrowth assay (Fig. 5), 
which measures AtCCD7 and/or AtCCD8 activity. 
However, although D5 and D6 were poor in the E. 
coli assays they showed the largest effect on 
whole Arabidopsis plants, giving the greatest 
number of side branches. Also D1 and D3 
appeared to be good inhibitors of the 9,10 
enzymes in vitro (Table 1), in E. coli (Fig. 4) and 
in the bud outgrowth assay (Fig. 5), but D3 had 
negative effects on growth which confounded the 
branching assay in whole plants, whereas plants 
treated with D1 grew normally and without an 
increase in branching. D1 and D3 both contained a 
more polar hydroxyl group on the aryl ring, 
therefore it is possible that these compounds are 
more actively transported or metabolised in the 
plant. 
Overall, the different activities observed in 
different assays suggest that factors such as 
uptake, metabolism, and effects on non-target 
processes may play a role in determining the 
suitability and effectiveness of the inhibitors in 
planta. Our results underline the importance of 
performing secondary screens in the biological 
systems where the compounds are to be used. Here 
we have been able to demonstrate that D2, D4, D5 
and D6 appear to inhibit CCDs in all the assays 
tested, including in planta, without negative 
unintended effects on whole plants. These 
compounds represent useful chemical genetic 
agents to explore the function of CCDs in plants, 
animals and micro-organisms. 
Using the inhibitors described here, it will now 
be possible to inhibit the CCD(s) involved in 
branching in a wide range of plant species and 
then look for changes in carotenoids and 
apocarotenoids – this could provide a powerful 
approach for the identification of the precursors of 
strigolactone, the identity of other active 
strigolactone-related compounds, and to the 
further elucidation of the biosynthetic pathway. 
The inhibitors could also be used to probe for 
functional variation in the role of strigolactone 
between species. Branching-promoting chemicals 
may have applications in horticulture where 
compact plant architecture is often highly 
desirable, e.g. in orchard crops (50). 
Other biological systems where genetic 
manipulations are not practical include the 
production of saffron (9) and bixin (49) in Crocus 
and Bixa plants respectively, where the in vivo 
substrates of the CCDs involved are not clear, and 
also in the study of the functions of mycorradicin 
and strigolactone in plant interactions with 
mycorrhyza (51) and parasitic weeds (15), 
respectively. Finally, there may be pharmaceutical 
applications for inhibitors of BCO2 in humans 
because products from 9,10 carotenoid cleavage 
have been implicated in DNA damage and 
carcinogenesis (52,53). 
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FIGURE LEGENDS 
 
FIGURE 1.  
Reactions catalysed by the carotenoid cleavage dioxygenases: a, 11,12-oxidative cleavage of 9′-cis-
neoxanthin by NCED; b, oxidative cleavage reactions on β-carotene and zeaxanthin. 
 
FIGURE 2.  
Synthetic route for preparation of hydroxamic acids inhibitors. 
 
FIGURE 3.  
Inhibitor design. Protonated abamine (a), a carotenoid carbocation intermediate (b) and a hydroxamic acid 
inhibitor (c) are shown bound to iron(II) cofactor of a CCD. 
 
FIGURE 4.  
The relative inhibition of four CCDs in E. coli. CCD genes were expressed in E. coli strains that produce 
β-carotene. The strains were grown in the presence or absence of inhibitors (100 µM) for 16 hours. This 
concentration of inhibitor was within the linear range of the E. coli response (see supplemental Fig. S2). 
The relative inhibition of each class of CCD was determined by the increase in β-carotene accumulation 
in the presence of the inhibitor, a value of 0 would indicate β-carotene levels equal to when no inhibitor 
was present and a value of 100 would equal the maximum level of β-carotene as observed in strains 
lacking a CCD (see Experimental Procedures for equation). Error bars represent the standard error of the 
mean, n = 4. The floating black bar represents the least significant difference (P < 0.05) for comparison of 
any two means. 
 
FIGURE 5.  
The effect of inhibitors on the outgrowth of buds from excised Arabidopsis nodes in the presence of 1 µM 
NAA. The graph shows lag time before the commencement of bud outgrowth for Col-0 (WT) in the 
presence or absence of 100 μM inhibitor. A null mutant of AtCCD7 (max3) was included without 
inhibitor as control. Values represent means from five independent experiments; n = 35 (WT), n = 18 
(max3), n = 14-16 (WT plus inhibitors). The floating black bar represents the least significant difference 
for comparison of any two means, and asterisks indicate values significantly different from the WT (P < 
0.05). 
 
FIGURE 6.  
Branching phenotypes of Arabidopsis plants grown in agar media for 45 days supplemented with 
inhibitor D6. Images are shown: (a) Col-0 (WT) without inhibitor; (b) max3-9 mutant without inhibitor; 
(c) Col-0 with 100 μM D6.  The numbers of rosette branches were also quantified (d).  Error bars 
represent standard error of the mean, n = 6 to 12. 
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Table 1.  
Inhibition of recombinant LeCCD1a and LeNCED1 enzymes using in vitro assays. Enzyme 
assays, using E. coli cell extracts containing the recombinant CCD, were initially carried out at 
100 µM inhibitor concentration; for compounds showing ≥ 95% inhibition of LeCCD1a at this 
concentration, IC50 values were also determined. NT, not tested. Chemical structures of 
hydroxamic acid inhibitors are shown below, with X and Y given in the table. The structure of 
abamine is given in Fig. 3. 
Inhibitor LeCCD1a (9,10/9′,10′) 
LeNCED1 
(11,12) 
Class Name X Y Inhibition @ 100 µM (%) 
IC   50
(µM)
Inhibition @ 
100 µM (%) 
Abamine     35 ± 15a 210 20 
F1 4-OMe H >95 2.0 0 
F2 4-OMe F >95 2.5 0 
F3 3,4-(OMe)2 H 50  2 
Aryl-C1N 
F4 3,4-(OMe)2 F 0  0 
D1 4-OH H >95 0.9 27 
D2 4-OH F >95 0.8 29 
D3 3,4-(OH)2 F >95 0.8 4 
D4 4-OMe F >95 2.5 33 
D5 3,4-(OMe)2 H >95 8.0 8 
D6 3,4-(OMe)2 F >95 9.0 18 
Aryl-C2N 
D7 3,4-OCH2O F >95 3.0 33 
D8 3,4-(OMe)2 CH2Ph 61  40 
D9 4-OMe CH2Ph >95 10 27 
D10 3,4-(OMe)2 n-octyl 65  14 
D11 4-OMe n-octyl 53  15 
D12 3,4-(OMe)2 H 26  11 
Aryl-C3N 
D13 4-OMe H 46  13 
Ring-C5N B1   90 20 5 
a mean and range of two independent experiments 
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